LINC00850

Across TCGA pan-cancer cohorts, LINC00850 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC00850 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC00850 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00850 expression acts as an unfavorable survival marker, although some lineages such as LGG and TGCT show a favorable association.

KIRC, READ, and KICH are the cancer types where LINC00850 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.088	0.641	<.001	87	view →
READ	DFS	Tertile	II,III,IV	0.027	0.818	<.001	54	view →
KICH	DFS	Tertile	II,III,IV	0.043	0.950	<.001	48	view →
DLBC	OS	Tertile	II,III,IV	0.115	0.839	<.001	36	view →
STAD	DFS	Tertile	All	0.501	0.728	.026	27	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	27	view →
BRCA	DFS	Tertile	II,III,IV	0.805	0.894	.017	18	view →
THYM	OS	Tertile	All	0.381	0.879	.003	15	view →
KIRP	DFS	Tertile	All	0.185	0.610	.035	6	view →
LGG	OS	Tertile	All	1.000	0.803	.044	3	view →
TGCT	DFS	Median	All	0.808	0.611	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC00850–KIRC (DFS)

Open the KIRC breakdown →